Avantor (AVTR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
Q3 net sales grew 4.6% reported and 5.2% organically, exceeding management expectations as VWR and BMP both returned to organic growth.
FY2026 organic revenue, Adjusted EPS and free cash flow guidance increased; Adjusted EBITDA margin guidance was unchanged.
Strong cash generation supported investment and debt reduction; adjusted net leverage ended Q3 at 3.1x.
Financial highlights
Q3 net sales were $1,698.3M, up 4.6% reported and 5.2% organically YoY.
Adjusted EBITDA was $256.9M, down 4.1% YoY, with a 15.1% margin versus 16.5%; Adjusted EPS was $0.22.
Free cash flow was $156.2M; excluding $13M of cash restructuring costs, it was $169M.
Gross profit rose to $534.8M, while gross margin contracted 90 bps to 31.5% amid unfavorable mix and inflation.
GAAP net income was $203.4M versus a $711.8M loss YoY; adjusted net income was $146.4M versus $151.1M.
Outlook and guidance
FY2026 organic revenue growth guidance rose to 0.75%-1.25% from -0.5%-0.5%; reported revenue growth guidance is 1.5%-2.0%.
Adjusted EPS guidance increased to $0.81-$0.83 and free cash flow guidance to $525M-$550M; Adjusted EBITDA margin guidance remained 14.8%-15.3%.
Guidance assumptions include a 22.0%-22.5% adjusted tax rate, 679M diluted shares, EUR/USD of 1.15 and a 0.75% FX tailwind to reported revenue growth.
Q4 VWR growth is expected in the mid-single digits; BMP is expected flat to slightly positive YoY, with ~400 bps of discrete comparison headwinds.
Latest events from Avantor
- Organic growth, stronger margins, and IPO-funded deleveraging marked 2019.AVTR
Q4 2019 - Biopharma-led growth lifted sales, margins and cash flow despite uneven pandemic impacts.AVTR
Q4 2020 - 11.3% organic growth, 190-bps margin expansion and $4B+ deployed across three acquisitions.AVTR
Q4 2021 - Core growth and margin gains offset FX headwinds as cash funded debt reduction and expansion.AVTR
Q4 2022 - FY23 sales and EBITDA fell, while free cash flow topped $723M amid weak demand.AVTR
Q4 2023 - Q2 2026 delivered higher sales, strong cash flow, and raised guidance amid improved segment results.AVTR
Q2 2026 - All proposals passed, directors elected, and no questions raised during the meeting.AVTR
AGM 2026 - Q2 2025 net sales and margins declined, with guidance cut and a CEO transition announced.AVTR
Q2 2025 - Q4 growth, margin gains, and strong cash flow support continued improvement and deleveraging in 2025.AVTR
Q4 2024